Article
Characterisation of a novel ACE2-based therapeutic with enhanced rather than reduced…
medRxiv · 2021 · Ferrari, M.; Mekkaoui, L.; Ilca, F. T.; Akbar, Z.; Bughda, R.; Lamb, K.; Ward, K.; Parekh, F.; Karattil, R.; Allen, C.; Wu, P.; Baldan, V.; Mattiuzzo, G.; Bentley, E. M.; Takeuchi, Y.; Sillibourne, J.; Datta, P.; Kinna, A.; Pule, M.; Onuoha, S.
Key facts
| Title | Characterisation of a novel ACE2-based therapeutic with enhanced rather than reduced activity against SARS-CoV2 variants |
|---|---|
| First author | Ferrari, M.; Mekkaoui, L.; Ilca, F. T.; Akbar, Z.; Bughda, R.; Lamb, K.; Ward, K.; Parekh, F.; Karattil, R.; Allen, C.; Wu, P.; Baldan, V.; Mattiuzzo, G.; Bentley, E. M.; Takeuchi, Y.; Sillibourne, J.; Datta, P.; Kinna, A.; Pule, M.; Onuoha, S. |
| Journal | medRxiv |
| Published | Mar 18, 2021 |
| DOI | 10.1101/2021.03.17.435802 |
| Devices mentioned | K202641, K231013 |
| Product codes mentioned | MVU, QBD |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1